HealthLynked Corp. (OTCQB: HLYK), a healthcare technology company focused on AI-powered patient engagement, care coordination and provider connectivity, has selected DRCARE247 as its telemedicine partner. The partnership will integrate virtual care capabilities directly into the HealthLynked mobile application and website, allowing users to transition from AI-powered health guidance to provider discovery, appointment scheduling, virtual consultations and medical record management within a single platform.
The integration matters because it closes a longstanding gap in digital health: patients often receive AI-generated health advice but then face fragmented steps to find a doctor, book a visit and share records. By embedding DRCARE247’s telemedicine services, HealthLynked aims to create a seamless, end-to-end experience that could increase patient adherence to follow-up care and reduce costly emergency visits or delayed treatments. The company expects to begin launching the integrated telemedicine platform in selected geographic regions over the next three months, followed by expansion into additional U.S. markets, subject to provider availability and applicable state requirements.
The virtual care feature is expected to work alongside HealthLynked’s AI-powered patient assistant and, where clinically appropriate and permitted, may include prescription management as part of virtual consultations. That capability could further differentiate HealthLynked in a crowded telehealth market, where many standalone apps offer either AI triage or video visits, but rarely both in a unified workflow. For investors, the partnership signals execution on the company’s strategy to become a comprehensive care coordination hub rather than a single-function tool.
HealthLynked’s cloud-based platform already connects patients with providers for virtual or in-office appointments and consolidates medical records into one secure, accessible location. With AI-driven insights, integrated telehealth services, and intelligent patient engagement tools, the company empowers patients and providers to coordinate care more effectively while delivering savings on prescriptions and healthcare services. The platform also supports enterprise partnerships, offering scalable solutions to healthcare networks, employers, insurers, accountable care organizations, and digital health innovators.
The timing of the DRCARE247 selection is notable as telehealth utilization remains elevated post-pandemic, yet many patients still struggle with disjointed digital tools. By integrating telemedicine into its core app, HealthLynked could improve retention and engagement metrics, which are key value drivers for enterprise clients such as insurers and accountable care organizations. The company’s newsroom at https://ibn.fm/HLYLK provides ongoing updates on HLYK developments.
BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers access to a vast network of wire solutions via InvestorWire, article and editorial syndication to 5,000+ outlets, enhanced press release enhancement, social media distribution and a full array of tailored corporate communications solutions. For more information, visit https://www.BioMedWire.com.
